|
CN1833030B
(zh)
|
2003-05-22 |
2014-07-23 |
美国弗劳恩霍夫股份有限公司 |
用于表达、传递及纯化目标多肽的重组载体分子
|
|
EP1919504B1
(en)
|
2005-08-03 |
2013-10-16 |
iBio, Inc. |
Antibody to bacillus anthracis protective antigen
|
|
CN102046654A
(zh)
*
|
2007-03-13 |
2011-05-04 |
胡马斯有限公司 |
针对甲型流感病毒h5n1株系的抗体
|
|
US8404252B2
(en)
|
2007-07-11 |
2013-03-26 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
|
CA2731686C
(en)
|
2008-07-25 |
2020-04-07 |
Institute For Research In Biomedicine |
Neutralizing anti-influenza a virus antibodies and uses thereof
|
|
US8871207B2
(en)
|
2008-07-25 |
2014-10-28 |
Humabs, LLC |
Neutralizing anti-influenza A virus antibodies and uses thereof
|
|
WO2010037046A1
(en)
|
2008-09-28 |
2010-04-01 |
Fraunhofer Usa, Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
|
GB0818356D0
(en)
*
|
2008-10-07 |
2008-11-12 |
Istituto Superiore Di Sanito |
Antibodies
|
|
ES2525346T3
(es)
|
2008-10-22 |
2014-12-22 |
Institute For Research In Biomedicine |
Métodos para producir anticuerpos a partir de células plasmáticas
|
|
KR101790354B1
(ko)
|
2009-05-11 |
2017-10-25 |
얀센 백신스 앤드 프리벤션 비.브이. |
인플루엔자 바이러스 ｈ3ｎ2를 중화시킬 수 있는 인간 결합 분자 및 그것의 용도
|
|
US8784819B2
(en)
*
|
2009-09-29 |
2014-07-22 |
Ibio Inc. |
Influenza hemagglutinin antibodies, compositions and related methods
|
|
EP2603237A4
(en)
*
|
2010-08-12 |
2014-05-21 |
Theraclone Sciences Inc |
ANTI-HEMAGGLUTININE ANTIBODY COMPOSITIONS AND METHOD FOR THEIR USE
|
|
CN102775469B
(zh)
*
|
2011-05-12 |
2018-02-09 |
厦门大学 |
甲型流感病毒核衣壳蛋白的抗原表位及其用途
|
|
HUE044089T2
(hu)
|
2011-07-18 |
2019-09-30 |
Inst Res Biomedicine |
Neutralizáló anti-influenza A antitestek és alkalmazásaik
|
|
JP2013087069A
(ja)
*
|
2011-10-17 |
2013-05-13 |
Toyobo Co Ltd |
Ｈ５亜型インフルエンザウイルスを特異的に認識するモノクローナル抗体
|
|
MX367743B
(es)
|
2011-12-05 |
2019-09-04 |
Trellis Bioscience Llc |
Anticuerpos utiles para la inmunizacion pasiva de influenza.
|
|
WO2013105896A1
(en)
*
|
2012-01-12 |
2013-07-18 |
Temasek Life Sciences Laboratory Limited |
Monoclonal antibodies targeting neutralizing epitopes on h5 influenza virus of clade 2.3
|
|
US9969794B2
(en)
|
2012-05-10 |
2018-05-15 |
Visterra, Inc. |
HA binding agents
|
|
BR112015010817A8
(pt)
|
2012-11-13 |
2018-01-23 |
Genentech Inc |
anticorpos anti-hemaglutinina isolado, método de tratamento, inibição ou prevenção de infecções, composição, composição farmacêutica, ácido nucleico isolado, célula hospedeira, método de produção de anticorpos e uso do anticorpo anti-hemaglutinina
|
|
IL241552B2
(en)
*
|
2013-03-14 |
2023-09-01 |
Contrafect Corp |
Preparation and methods based on neutralizing antibodies administered intranasally for increased therapeutic efficacy
|
|
SG11201602522VA
(en)
|
2013-10-02 |
2016-04-28 |
Medimmune Llc |
Neutralizing anti-influenza a antibodies and uses thereof
|
|
US10639370B2
(en)
|
2014-02-04 |
2020-05-05 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
AU2015214146B2
(en)
|
2014-02-04 |
2020-09-17 |
Contrafect Corporation |
Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof
|
|
KR101628331B1
(ko)
*
|
2014-03-28 |
2016-06-08 |
주식회사 녹십자엠에스 |
인플루엔자 a 바이러스 특이적 단클론 항체 및 이를 이용한 인플루엔자 감염 치료 및 진단 방법
|
|
JP6614523B2
(ja)
*
|
2014-03-28 |
2019-12-04 |
地方独立行政法人神奈川県立産業技術総合研究所 |
インフルエンザウイルスのｒｎａ依存性ｒｎａポリメラーゼのｐｂ２サブユニットに対するモノクローナル抗体
|
|
WO2016011035A2
(en)
|
2014-07-15 |
2016-01-21 |
Medlmmune, Llc |
Neutralizing anti-influenza b antibodies and uses thereof
|
|
TWI701258B
(zh)
|
2014-12-19 |
2020-08-11 |
美商再生元醫藥公司 |
流行性感冒病毒血球凝集素之人類抗體
|
|
WO2016200543A2
(en)
|
2015-05-13 |
2016-12-15 |
The Trustees Of The University Of Pennsylvania |
Aav-mediated expression of anti-inluenza antibodies and methods of use thereof
|
|
MX389708B
(es)
|
2015-06-01 |
2025-03-20 |
Medimmune Llc |
Neutralizacion de moleculas de union anti-influenza y usos de las mismas.
|
|
WO2017083627A1
(en)
|
2015-11-13 |
2017-05-18 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
JP2019502715A
(ja)
|
2016-01-13 |
2019-01-31 |
メディミューン，エルエルシー |
Ａ型インフルエンザを治療する方法
|
|
CA3015347A1
(en)
|
2016-02-24 |
2017-08-31 |
Visterra, Inc. |
Formulations of antibody molecules to influenza virus
|
|
PL238020B1
(pl)
*
|
2016-09-12 |
2021-06-28 |
Inst Biotechnologii I Antybiotykow |
Kompozycja przeciwciał monoklonalnych przeciwko hemaglutyninie wirusów grypy serotypu H5 i jej zastosowanie, hybrydomy produkujące rzeczone przeciwciała, sposób diagnozowania infekcji wirusami grypy serotypu H5 oraz zestawy diagnostyczne
|
|
TW201837170A
(zh)
|
2017-02-28 |
2018-10-16 |
賓州大學委員會 |
新穎ａａｖ媒介的流感疫苗
|
|
RS65241B1
(sr)
|
2017-02-28 |
2024-03-29 |
Univ Pennsylvania |
Vektor adeno-asociranih virusa (aav) iz podgrupe f i njegove upotrebe
|
|
JOP20190200A1
(ar)
|
2017-02-28 |
2019-08-27 |
Univ Pennsylvania |
تركيبات نافعة في معالجة ضمور العضل النخاعي
|
|
JP7234142B2
(ja)
|
2017-06-02 |
2023-03-07 |
ファイザー・インク |
Ｆｌｔ３に特異的な抗体およびその使用
|
|
EP3946613A1
(en)
|
2019-03-25 |
2022-02-09 |
Visterra, Inc. |
Compositions and methods for treating and preventing influenza
|
|
EP4087590A4
(en)
*
|
2020-01-12 |
2024-05-15 |
Vanderbilt University |
Human antibodies to crimean congo hemorrhagic fever virus
|
|
WO2021202815A1
(en)
*
|
2020-03-31 |
2021-10-07 |
Northeastern University |
Colorimetric and multiplexed isothermal rna-and antibody-based assay for sars-cov-2 and other viral diagnostics and cell analysis
|
|
CN114181302B
(zh)
*
|
2020-09-14 |
2023-03-24 |
东莞市朋志生物科技有限公司 |
针对甲型流感病毒的抗体、试剂盒和载体
|
|
US12649790B2
(en)
|
2023-07-03 |
2026-06-09 |
Medicovestor, Inc. |
Proteins that bind SP17 including fully-human anti-SP17 antibodies
|
|
US12624097B2
(en)
|
2023-07-03 |
2026-05-12 |
Medicovestor, Inc. |
Nucleic acids, vectors, and cells that encode anti-Sp17 antibodies and other Sp17 binding proteins
|
|
US12319747B2
(en)
*
|
2023-07-03 |
2025-06-03 |
Medicovestor, Inc. |
Methods of using anti-SP17 immunotherapeutics
|
|
US12364777B2
(en)
|
2023-10-20 |
2025-07-22 |
Medicovestor, Inc. |
Homodimeric antibodies for use in treating cancers and methods of use
|
|
US12600795B2
(en)
|
2023-12-26 |
2026-04-14 |
Medicovestor, Inc. |
Oligomeric IgG for immunotherapeutics and diagnostics
|
|
US12121587B1
(en)
|
2023-12-26 |
2024-10-22 |
Medicovestor, Inc. |
Dimeric antibodies
|
|
US12116410B1
(en)
|
2023-12-26 |
2024-10-15 |
Medicovestor, Inc. |
Methods of manufacturing dimeric antibodies
|
|
US12673991B2
(en)
|
2023-12-26 |
2026-07-07 |
Medicovestor, Inc. |
Methods of crosslinking IgG
|
|
WO2025245380A1
(en)
*
|
2024-05-22 |
2025-11-27 |
Vanderbilt University |
Antibody generation
|